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The Notch pathway plays an important role in ovary development in invertebrates like Drosophila.
However its role for the mammalian ovary is unclear. Mammalian Hes genes encode transcriptional
factors that mediate many of the activities of the Notch pathway. Here, we have studied the function of
Hes1 during embryonic development of the mouse ovary. We ﬁnd that Hes1 protein is present in
somatic cells and oocyte cytoplasm and decreases between E15.5 and P0. Conventional Hes1 knock-out
(KO), Hes1 conditional KO in the ovarian somatic, and chemical inhibition of Notch signaling decrease
the total number, size and maturation of oocytes and increase the number of pregranulosa cells at P0.
These defects correlate with abnormal proliferation and enhanced apoptosis. Expression of the
proapoptotic gene Inhbb is increased, while the levels of the antiapoptotic and oocyte maturation
marker Kit are decreased in the Hes1 KO ovaries. Conversely, overactivation of the Notch pathway
in ovarian somatic cells increases the number of mature oocytes and decreases the number of
pregranulosa cells. Fertility is also reduced by either Hes1 deletion or Notch pathway overactivation.
In conclusion, our data suggest that the Notch–Hes1 pathway regulates ovarian somatic cell development,
which is necessary for oocyte survival and maturation.
& 2012 Elsevier Inc. All rights reserved.Introduction
The Notch pathway is crucial for tissue homeostasis and
patterning in many organs (Andersson et al., 2011). It also plays
an important role in the development of invertebrate follicles in
Caenorhabditis elegans and Drosophila melanogaster (Klusza and
Deng, 2011; Waters and Reinke, 2011). However, the role of the
Notch pathway in the mammalian ovary development is still
unclear.
The Notch proteins are one-transmembrane receptors that
consist of an extracellular domain, a transmembrane domain
and an intracellular domain (NICD). The Notch receptors are
bound by Jagged and Delta ligands and modulated by Fringe
glycosyltransferases (Andersson et al., 2011). Binding between
ligand and receptor results in the cleavage of the NICD, transloca-
tion of NICD into the nucleus and binding to the Rbpj transcrip-
tion factor for target gene activation. Among the target genes, thell rights reserved.
Research, Kyoto University,
va),
de Biologie Mole´culaire et
4, Universite´ de Strasbourg,family of Hes transcription factors are important mediators of
Notch signaling by repressing differentiation related genes
(Kageyama et al., 2007).
The role of the Notch pathway in invertebrate oocyte develop-
ment is relatively well understood. In Drosophila, germ cell-derived
Delta activates the Notch receptor in the somatic follicle cells and
regulates cell growth and exit from the mitotic cell cycle (Klusza and
Deng, 2011). In C. elegans, Delta in the somatic cells activates the
Notch receptor in the germline stem cells to regulate the balance
between meiosis and mitosis (Waters and Reinke, 2011).
Murine oocyte development starts when primordial germ cells
(PGC) originate from epiblast cells at embryonic day (E)7.5 and
populate the gonads at around E10.5. At E13.5, somatic cells divide
and surround the oocyte forming cysts (Pepling and Spradling,
1998). Between E13.5 and postnatal day (P)0, oocytes grow and
progress through different stages of prophase I (Speed, 1982).
Between E18.5 and P0, the majority of oocytes are depleted by
apoptosis, possibly by some selection process (Ghafari et al., 2007).
The mouse oocytes express the Notch ligand Jag1 whereas
ovarian somatic cells express the Notch receptors Notch2 and
Notch3, the glycosyltransferase Lunatic Fringe (Lfng) and the
downstream transcriptional effector Hes1 among other Notch
pathway genes (Johnson et al., 2001; Hahn et al., 2005).
Functional studies have shown that chemical inactivation of the
Notch pathway in explant newborn ovaries results in follicles
I. Manosalva et al. / Developmental Biology 375 (2013) 140–151 141containing more than one oocyte (multi-oocyte follicles)
(Trombly et al., 2009). Multi-oocyte follicles, abnormal meiosis
and reduced fertility have been also reported in the Lfng knock-
out (KO) mice (Hahn et al., 2005). In addition, ovarian cancer cells
show abnormal expression of Notch pathway genes, and their
growth and apoptosis can be controlled with chemical inhibitors
of the Notch pathway (Hopfer et al., 2005; Wang et al., 2010).
Despite these studies, the exact function of Notch signaling in the
ovary remains to be determined.
To investigate the function of the Notch pathway for the
mammalian ovary development, we analyzed conventional and
somatic cell-speciﬁc Hes1 KO ovaries as well as somatic cell-
speciﬁc overactivation of the Notch pathway in the ovary. Our
results suggest that Hes1 in the somatic cells supports oocyte
maturation and survival at P0. These data uncover a new role of
the Notch pathway for the mammalian ovary development.Materials and methods
Animals
The presence of vaginal plug was considered as day 0.5 of
gestation. Genotyping was carried out as previously described:
Hes1 KO (Ishibashi et al., 1995), Hes1 ﬂox (Imayoshi et al., 2008),
Amhr2-cre (Jamin et al., 2002), TNAP-Cre (Lomelı´ et al., 2000), and
ROSA-NICD (Murtaugh et al., 2003). All experiments were carried
out at postnatal day 0 (P0) unless indicated otherwise. All animals
were handled in accordance with the Kyoto University Guide for
the Care and Use of Laboratory Animals.
In situ hybridization and real-time PCR
In situ hybridization was carried out using the mouse Hes1
probe as previously described (Imayoshi et al., 2008). For
real-time PCR, RNA was isolated from ovaries using the standard
Trizol procedures. Reverse transcription reaction and quantitative
PCR were performed with ReverTraAce and SYBR Green (Toyobo),
respectively. Real-time PCR measurement and normalization
were carried out as previously described (Kobayashi et al.,
2009). Gapdh, which does not change in the Hes1 KO samples,
was used as housekeeping (supplementary Fig. S1). Primers are
shown in supplementary Table S1.
Immunohistochemistry
For immunohistochemistry of cryosections, samples were
included in OCT, cut (10 mm), postﬁxed in formalin for 10 min
and then washed in PBS for 5 min (3 times). Antigen retrieval
(0.01M sodium citrate buffer, 10 min at 100 1C) was performed
for all antibodies with the exception of Pecam1 and Ngfr. Sections
were washed in PBS and blocked (5% serum and 0.1% Triton X-100
in PBS) for 2 h at room temperature. Primary antibodies were
diluted in the blocking solution and incubated overnight at 4 1C.
Secondary antibodies and DAPI were incubated for 1 h at room
temperature. Primary antibodies and dilution rates were as
follows: cleaved Caspase 3 (1:100, Cell Signaling #9661), Ki67
(1:100, BD Pharmingen #556003), Kit (1:100, Calbiochem
#961–976), Hes1 (1:200, Kobayashi et al. (2009)), Ngfr (1:100,
Promega G323A), Pecam1 (1:100, BD Pharmingen #550274), Sycp3
(1:100, Abcam ab15092), and Tra98 (1:1000, B-Bridge #73-003).
For immunohistochemistry of parafﬁn sections, embryos were ﬁxed
in 4% PFA, overnight at 4 1C, parafﬁn embedded and sectioned
(10 mm). Deparafﬁnized sections were subjected to antigen retri-
eval, endogenous peroxidase quenching, blocking and incubation
with primary antibody (1:200, Hes1, Kobayashi et al. (2009)), andFoxl2 (1:200, NB100-1277). Detection was carried out with
biotinylated secondary antibodies of the VECTASTAIN ABC kit.
Slides were developed using DAB. As positive and negative
controls for the Hes1 antibody, we show nuclear immunohisto-
chemistry staining in WT ﬁbroblasts and absent staining in Hes1
KO ﬁbrablasts and ovaries (supplementary Fig. S2A and B).
Bromodeoxyuridine (BrdU), Tunel and luciferase assays
For the BrdU assay, pregnant mice received a single injection
of BrdU (50 mg/kg, BD Biosciences #347580) at E15.5 and
E18.5, 2 h before collection. Ovaries were treated similarly as
for immunoﬂuorescence (see below) except that the antigen
retrieval step was substituted by a treatment with DNAse I (Roche
Diagnostic) for 60 min at 37 1C. For the Tunel assay, parafﬁn
sections were deparafﬁnized and rehydrated. The Tunel protocol
was taken from the instructions provided by the kit (Chemicon
International). The luciferase assay was carried out as previously
described using C3H10T1/2 cells in 10% FBS/DMEM and Lipo-
fectamin LTX/Plus (Invitrogen) transfection reagent (Masamizu
et al., 2006).
Ovary culture
Ovary culture was carried out as previously described with
small variations (Tang et al., 2008). Ovaries from E17.5 CD-1 mice
were dissected, bursal sac was removed in PBS and ovaries were
put in 0.4-mm ﬂoating ﬁlters (Millicell-CM; Millipore Corporation,
Billerica, MA) and cultured for 4 days at 37 1C in a chamber
containing 5% CO2. Medium DMEM-F12 suplemented with 0.1%
Albumax (Invitrogen), penicillin–streptomycin (Invitrogen), 0.1%
BSA (Sigma), 27.5 mg/ml transferrin (Sigma), and 0.05 mg/ml
l-ascorbic acid (Sigma). Treatments were DAPT dissolved in DMSO
(20 mM, Calbiochem) and recombinase Inhibin b (100 ng/ml, R&D
Systems 659-AB). Cultured ovaries follow the histology treatment
of the RT-PCR described before.
Oocyte collection
To retrieve MII-arrested oocytes, mice were superovulated by
intraperitoneal injection of 5 IU PMSG followed by 5 IU hCG 48 h
later. Cumulus enclosed oocytes complexes were collected from the
ampulla of oviducts 13 h after hCG injection, placed in M2 medium,
and freed of cumulus cells with 1mg/ml hyaluronidase. DAPI staining
was carried out after ﬁxing the MII oocytes with 4% PFA for 5 min.
Fluorescence was captured with a confocal scaning system.
Quantiﬁcation and statistical analysis
We counted the total number of positive cells from sections
(30 mm apart) of the entire ovary and rescaled it with the WT
number. For quantiﬁcation of the Pecam1 signal, the Pecam1
color channel was binarized and the positive area percentage was
computed with ImageJ (NIH, Bethesda, USA). All experiments
were carried out in 3 or more animals unless indicated otherwise.
To calculate statistical signiﬁcance, differences between control
and mutant populations were evaluated with Student’s t test.
A P-value less than 0.05 was considered signiﬁcant.Results
Hes1 expression dynamics in the fetal ovary
We ﬁrst investigated the expression dynamics of Hes1 in the
fetal ovary. We carried out in situ hybridization with a probe for
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at E15.5 at low levels and further decreases at E17.5 (Fig. 1A).
Real-time PCR with Hes1 primers in cDNA samples from ovaries at
E15.5, E17.5 and P0 stages also showed low levels of Hes1 mRNA
expression that decreased with increasing age (Fig. 1B). We also
investigated the levels of Hes1 protein at different stages by
immunohistochemistry. At E15.5, many ovarian cells show low
levels of Hes1 protein staining (left column in Fig. 1C). From this
stage on, Hes1 protein progressively decreased at E17.5 and P0
stages (left column in Fig. 1C). Hes1 and Tra98 immunohisto-
chemistry signals did not overlap suggesting that Hes1 was
absent from the oocyte nuclei (middle and right columns in
Fig. 1C). Higher magniﬁcation images showed that Hes1 protein
is present in the oocyte cytoplasm and in the nuclei of surround-
ing somatic cells at P0 stage (supplementary Fig. S3) (Trombly
et al., 2009).These data suggest that Hes1 mRNA expression
decreases between E15.5 and P0, and that Hes1 protein is mainly
present in oocyte cytoplasm and somatic cells.Fig. 1. Hes1 expression dynamics and localization in fetal ovaries. (A,B) Hes1 mRNA ex
expressed at low levels and decreases between embryonic stages E15.5 and birth. (C) D
protein is stained at low levels (contrast increased to show more detail) and decreases b
do not colocalize suggesting that Hes1 is excluded from oocyte nuclei. Boxed regions aHes1 expression is known to oscillate in different tissues like the
presomitic mesoderm, neuronal precursors and embryonic stem
cells (Masamizu et al., 2006; Shimojo et al., 2008; Kobayashi et al.,
2009). To investigate whether Hes1 also oscillates in the ovary, we
monitored the luminescence of trypsinized ovary cells from mice
carrying a Hes1 promoter luciferase reporter (Masamizu et al., 2006).
Hes1 expression was found to oscillate in ovary cells with a period of
about 3–6 h (supplementary Fig. S4).
Fewer and smaller oocytes and more pregranulosa cells in the
absence of Hes1
To investigate the function of Hes1, we examined the ovary of
conventional Hes1 KO mice (Ishibashi et al., 1995), some of which
survived until just after birth. Externally, the mutant ovaries were
similar to the control (supplementary Fig. S5). However, histolo-
gical analysis showed that grown follicles were present in the
wild-type (WT) but absent in the mutant ovaries at P0 (Fig. 2A).pression by in situ hybridization (n¼2) (A) and real-time PCR (B). Hes1 mRNA is
ouble immunohistochemistry of Hes1 protein and the oocyte marker Tra98. Hes1
etween E15.5 and P0 (left column). Hes1 and Tra98 immunohistochemistry signals
re enlarged in the third column. Scale bars: 50 mm; nnnPo0.001.
E15.5 E17.5 E19.5
E18.5 P0
E15.5 E17.5 E19.5
Fig. 2. The number and diameter of oocytes are reduced in the Hes1 KO mice. (A,B) Hematoxilin staining of ovaries at E18.5, E19.5 and P0 stages in the Hes1 KO and
quantiﬁcation. Grown oocytes are rare at E19.5 and absent at P0 in Hes1 KO ovaries. Quantiﬁcation shows a diameter decrease to about 60% after E19.5 (B). (C–H)
Immunoﬂuorescence and quantiﬁcation of the oocyte marker Tra98 (C,E), the meiosis marker Sycp3 (D,F) and the mature oocyte marker Kit (G,H). Oocytes marked by
Tra98 decrease in number since E17.5 in the Hes1 KO to about 50% (C,E). The ratio of Sycp3/Tra98 oocytes, which represents meiotic oocytes, decreases to about 60% at
E19.5 (D,F). The ratio of Kit/Tra98 oocytes, which represents mature oocytes, strongly decreases after E18.5 (G,H). Boxed regions are enlarged in the corners. Scale bars:
50 mm; nPo0.05, nnPo0.01, nnnPo0.001.
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E19.5 and a 50% lower diameter at P0 (Fig. 2B). We also examined
the number of oocytes by immunohistochemistry with the oocyte
marker Tra98. The number of oocytes in the mutants was
comparable to the WT at E15.5 but decreased to about 60% at
E17.5 and thereafter (Fig. 2C and E). Chromosomal defects could
not be detected (supplementary Fig. S6), but oocytes in meiosis
decreased to about 60% at E19.5 as evaluated by the meiotic
marker Sycp3 (Fig. 2D and F). Mature oocytes, which are labeled
by the Kit antibody, also decreased at P0 (Fig. 2G and H). Real-
time PCR of ligand Kitl and receptor Kit also showed lower
expression at P0 (supplementary Fig. S7). These data suggest that
the number and maturation of oocytes are decreased in Hes1
mutant ovaries.
We next examined whether differentiation of ovarian somatic
cells also changes in the absence of Hes1. For this purpose, we
carried out immunohistochemistry with different markers ofovarian somatic cells. Immunohistochemistry of the pregranulosa
cell marker Foxl2 showed that the number of pregranulosa cells
increases in Hes1 KO ovaries at E15.5 and E18.5 (Fig. 3A and B).
Foxl2 expression levels at E17.5 were also increased as evaluated
by real-time PCR (Fig. 3C). Other somatic markers like Fst and
Rspo1 also increased in the Hes1 KO ovaries (Fig. 3C). However,
the pregranulosa precursor marker Lhx9 decreased in the Hes1 KO
ovary (Fig. 3C). We also examined other somatic cell types in the
Hes1 mutant ovaries, namely medulla and endothelial cells. We
used Ngfr as a marker of medulla (stroma) cells (Uda et al., 2004).
Immunoﬂuorescence of the medulla marker Ngfr decreased in the
Hes1 KO ovaries (Fig. 3D). On the other hand, the area percentage
of the endothelial cell marker Pecam1 increased at E15.5 but
decreased at E19.5 (Fig. 3E and F). These data suggest that
pregranulosa cells increase in the Hes1 KO ovaries, while other
somatic cell types decrease. The equivalent cell type of pregra-
nulosa cells in the testis are Sertoli cells, which express Fgf9, Pdgfa
E15.5 E18.5
E18.5 E15.5 E17.5 E19.5P0
Fig. 3. The number of pregranulosa cells increases but medulla and endothelial cells decrease in the Hes1 KO mice. (A,B) Immunohistochemistry of the pregranulosa cell
marker Foxl2 at E15.5 and E18.5 stages. The number of Foxl2 positive cells increases in the Hes1 KO at E15.5 and E18.5. (C) Expression of the somatic cell makers Fst and
Rspo1, the pregranulosa cell marker Foxl2 and the pregranulosa precursor cell marker Lhx9 in the Hes1 KO by real-time PCR at E17.5. The mRNA expression levels of
somatic cell markers increase in the Hes1 KO. (D) Immunoﬂuorescence of the medulla cell marker Ngfr in mutant ovaries. The ﬂuorescence of the medulla cell marker Ngfr
decreases in the mutant ovaries at E18.5 and P0 embryonic stages. (E,F) Immunoﬂuorescence of the endothelial cell marker Pecam1 in Hes1 KO ovaries and quantiﬁcation.
The levels of the endothelial cell marker Pecam1 increase at E15.5 but decrease at E19.5. Boxed regions are enlarged in the corners. Scale bars: 50 mm; nPo0.05, nnPo0.01,
nnnPo0.001.
I. Manosalva et al. / Developmental Biology 375 (2013) 140–151144and Sox9. Real-time PCR with primers for these genes in female
mutant ovaries showed an increase of Fgf9 and Sox9 (supplemen-
tary Fig. S8). By contrast, expression of markers of male leydig
cells and interstitial cells decreased in the mutant ovaries
(supplementary Fig. S8). These observations suggest that Hes1-
null pregranulosa cells have mixed features of testicular Sertoli
cells. In conclusion, Hes1 deletion in the ovary results in lower
number, size and maturation of oocytes, and higher number of
pregranulosa cells.
Abnormal cell number in the Hes1 KO ovaries might arise from
altered proliferation and enhanced apoptosis
We then wanted to know whether the higher number of Foxl2
positive cells observed in the Hes1 KO ovaries is associated
with altered proliferation. Therefore, we analyzed proliferation in
the ovary by immunohistochemistry with Ki67. Ki67 is stronglyexpressed in somatic cells and weakly in oocytes, but we focused
on the strong somatic cell expression. Comparison of mutant and
WT ovaries showed more Ki67 positive cells at E15.5 and less at
E18.5 (Fig. 4A and C). We also carried out the BrdU incorporation
assay that labels the S-phase of the cell cycle. Immunohistochem-
istry with the BrdU antibody showed that BrdU incorporation is
enhanced at E15.5 and reduced at E18.5 (Fig. 4B and D). These
data suggest that proliferation is enhanced at E15.5 and reduced
at E18.5. We also examined the expression of cell cycle inhibitors
Cdkn1c and Gadd45g by real-time PCR in cDNA samples synthe-
sized from WT and Hes1 KO ovaries. Our data show that Cdkn1c
decreases at E15.5 and increases at E18.5, while Gadd45g
increases at E18.5 in agreement with the Ki67 and BrdU results
(Fig. 4E).
We also wanted to know the cause for the lower number of
oocytes in the Hes1 KO ovaries, so that we examined apoptosis
by Caspase3 immunohistochemistry and Tunel assay. Double
E15.5 E18.5 E15.5 E18.5
A
Fig. 4. Proliferation is increased at E15.5 and decreased at E18.5 in the Hes1 KO ovaries. (A,C) Ki67 immunoﬂuorescence in the Hes1 KO ovaries at E15.5 and E18.5 and
quantiﬁcation. The number of Ki67 labeled cells increases at E15.5 and decreases at E18.5. (B,D) BrdU immunoﬂuorescence in the Hes1 KO ovaries at E15.5 and E18.5 and
quantiﬁcation. The number of cells incorporating BrdU increases at E15.5 and decreases at E18.5. (E) Expression of the cell cycle inhibitor genes Cdkn1c and Gadd45g by
real-time PCR. The expression of Cdkn1c decreases at E15.5. Later at E18.5, the expression of both Cdkn1c and Gadd45g increases at E18.5. Boxed regions are enlarged in the
corners. Scale bars: 50 mm; nPo0.05, nnnPo0.001.
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higher number of oocytes in apoptosis at E15.5 and E19.5 (Fig. 5A
and B). The Tunel assay also showed an increase of apoptosis from
E16.5 onward in the mutant samples (Fig. 5C and D). Higher
magniﬁcation images suggested that the Tunel signal stained
oocyte nuclei. It was previously shown that ovarian apoptosis
can be induced by Inhbb expression (Liu et al., 2010). Therefore,
we measured the mRNA levels of Inhbb in Hes1 KO ovaries by real-
time PCR. Inhbb expression strongly increased in the Hes1 KO
ovaries at E18.5 and P0 (Fig. 5E). Hes1 usually acts as a transcrip-
tional repressor, so that one possibility is that Hes1 directly
represses the Inhbb promoter (Kageyama et al., 2007). To evaluate
this possibility, we carried out the luciferase assay after contra-
nsfection of an Inhbb promoter reporter and a Hes1 expression
plasmid in cultured cells (Dykema and Mayo, 1994). Our results
show that Hes1 is able to repress the Inhbb promoter (supple-
mentary Fig. S9). It was also observed that Inhbb expression is
upregulated in Wnt4 mutants (Liu et al., 2010). Therefore, it is
possible thatWnt4 expression is decreased in the Hes1 KO ovaries
and this upregulates Inhbb expression. Indeed, we found by
real-time PCR that Wnt4 expression is decreased in the Hes1 KO
ovaries (supplementary Fig. S10). To further investigate whether
Inhbb causes oocyte decrease through apoptosis, we cultured
E17.5 WT ovaries with recombinant Inhbb for 4 days and
examined oocyte number and apoptosis. We found that Inhbb
treatment induces a non-signiﬁcant decresase of oocyte number
(Fig. 5F and G). Furthermore, double Tra98/Caspase3 immunohis-
tochemistry showed a higher number of oocytes associated with
Caspase3 staining (Fig. 5F and H). These results suggest that Hes1
is necessary to decrease oocyte apoptosis and one possible
mechanism is the repression of Inhbb.
Chemical inhibition of the Notch pathway decreases the size
of oocytes and induces oocyte apoptosis
In several tissues, the Hes1 promoter is activated by the Notch
pathway (Kageyama et al., 2007). To check the requirement of the
Notch pathway for Hes1 promoter activation, we monitored theluminescence of ovaries carrying a Hes1 promoter luciferase
reporter in the presence of the chemical inhibitor DAPT. In the
control experiment, the Hes1 promoter reporter luminescence
remained constant for at least 7 h, whereas in the presence of
DAPT, Hes1 rapidly decreased (supplementary Fig. S11). We also
checked the levels of Hes1 protein by immunohistochemistry
after culturing ovaries with DAPT for 4 days. Our results show
that Hes1 protein levels are decreased by DAPT (supplementary
Fig. S2C). Because DAPT downregulates the Hes1 protein levels in
the ovary, we hypothesized that this inhibitor might induce some
of the phenotypes of the Hes1 KO. To test this hypothesis, we
cultured explant ovaries at E17.5 for 4 days in the presence of
DAPT. Oocytes in the DAPT-treated ovaries were smaller than the
control (Fig. 6A). Quantiﬁcation of the oocyte size showed that the
average diameter decreases by around 30% (Fig. 6B). Immunohis-
tochemistry with the oocyte marker Tra98 exhibited a 10%
decrease of the oocyte number (Fig. 6C and D). Immunostaining
of Caspase3 showed a 5-fold increase of apoptosis in the treated
sample (Fig. 6C and E). Furthermore, Inhbb expression was
increased by the DAPT-treatment (Fig. 6F). We also examined
the number of pregranulosa cells marked by Foxl2 and found a
higher number of these cells (Fig. 6G and H). These results suggest
that the Notch pathway is necessary for Hes1 expression, which
prevents apoptosis and supports oocyte growth.
Conditional KO of Hes1 in somatic cells decreases the number and
maturation of oocytes
To ﬁnd out whether Hes1 functions in germ cells, we crossed a
TNAP-Cre line with the ﬂoxed Hes1 line to generate oocyte speciﬁc
Hes1 conditional KO (cKO) mice (Lomelı´ et al., 2000; Imayoshi et al.,
2008). Histological analysis of these mice did not show signiﬁcant
differences of the oocyte size (supplementary Fig. S12). We also
crossed the TNAP-Cre line with a ﬂoxed Rbpj allele to generate oocyte
speciﬁc Rbpj cKO mice (Han et al., 2002). We analyzed these ovaries
for oocyte, somatic cell and endothelial cell number using Tra98, Cx43
and Pecam1 markers. In this experiment, we did not ﬁnd any
difference between control and mutant ovaries (supplementary
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Fig. 5. Apoptosis increases in the Hes1 KO ovaries. (A,B) Caspase3 immunoﬂuorescence at E15.5, E17.5 and E19.5 and quantiﬁcation. The number of oocytes with Caspase3
signal increases at E15.5 and E19.5. (C,D) Tunel staining at E16.5, E17.5, E18.5 and P0 and quantiﬁcation. The number of oocytes marked by Tunel increases at all stages. (E)
Inhbb expression by real-time PCR in the Hes1 KO ovaries. The expression of Inhbb increases strongly in the Hes1 KO ovaries. (F–H) Double immunoﬂuorescence of
Caspase3 and Tra98 in ovaries cultured with Inhbb and quantiﬁcation. The number of Tra98-positive oocytes exhibits a non-signiﬁcant decrease (G), while the number of
Caspase3-labeled oocytes increases in the Inhbb-treated ovaries (H). Boxed regions are enlarged in the corners. Scale bars: 50 mm; nPo0.05, nnPo0.01, nnnPo0.001.
I. Manosalva et al. / Developmental Biology 375 (2013) 140–151146Fig. S13). These data suggest that the Notch pathway does not play an
important role in oocytes for fetal ovary development.
Next, we examined the function of Hes1 in ovarian somatic
cells by using an Amhr2-cre mouse line that induces Cre mediated
recombination in almost all somatic cells of the ovary since E13.5
(Jamin et al., 2002). This mouse was crossed with Hes1 ﬂox mice
to conditionally delete Hes1 in ovarian somatic cells (Hes1 cKO).
First we checked whether the Hes1 allele was deleted in the Hes1
cKO by carrying real-time PCR and immunohistochemistry of
Hes1. Our results show a drastic decrease of Hes1 mRNA and
protein expression in the Hes1 cKO suggesting that the Hes1 allele
is deleted (supplementary Figs. S1B and S2D). The presence of
some Hes1 staining in the Hes1 cKO could be due to incomplete
recombination. Next, we examined these ovaries at P0 stage.
Histological analysis showed that oocytes in the somatic Hes1 cKO
ovaries appeared smaller than the control (Fig. 7A). Quantiﬁcationshowed that the diameter of mutant oocytes decreases to around
50% (Fig. 7B). Then, we examined the number of oocytes by Tra98
immunoﬂuorescence and found that the mutant ovaries had
around 60% fewer oocytes than the control ovaries (Fig. 7C
and D). The number of meiotic oocytes labeled by Sycp3 did not
change (data not shown). Mature oocytes labeled with Kit anti-
body decreased to 80% in the mutant ovaries (Fig. 7E and G).
Pregranulosa cells labeled by Foxl2 antibody presented a tendency
to a higher number of cells in the Hes1 cKO ovaries (Fig. 7F and H).
By contrast, the medula cell marker Ngfr slightly decreased in the
Hes1 cKO ovaries (Fig. 7I). The endothelial cell marker Pecam1
did not show signiﬁcant differences (data not shown). Thus,
inactivation of Hes1 in somatic cells recapitulated some of the
ovary defects in the conventional Hes1 KO mice, suggesting that
Hes1 in the somatic cells is important to regulate the oocyte
number and maturation.
Fig. 6. The gamma-secretase inhibitor DAPT inhibits growth and induces apoptosis of oocytes. E17.5 ovaries were cultured for 4 days in the presence of DMSO or 20 mM
DAPT. (A,B) Hematoxilin staining of ovary parafﬁn sections. In the DAPT-treated ovaries, the average diameter is about 25% smaller (B). (C–E) Double immunoﬂuorescence
of the oocyte marker Tra98 and the apoptosis marker Caspase3 and quantiﬁcation. The number of oocytes decreases by about 10% (D), while the number of cells
in apoptosis increases about 5-fold (E). (F) Expression of Inhbb in ovaries treated with DAPT as evaluated by real-time PCR. The levels of Inhbb mRNA increases in
DAPT-treated ovaries. (G,H) Immunohistochemistry of the pregranulosa cell marker Foxl2 and quantiﬁcation. The number of Foxl2 positive cells increases. Boxed regions
are enlarged in the corners. Scale bars: 50 mm; nPo0.05, nnPo0.01, nnnPo0.001.
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oocytes
If the role of the Notch pathway is mediated by Hes1, we
would expect that Notch overactivation upregulates Hes1 expres-
sion and induces some opposite phenotypes. To test this hypoth-
esis, we crossed the ROSA-NICD mouse line with the Amhr2-cre
to conditionally activate Notch1 (ca-Notch1) in ovarian somatic
cells at P0 (Murtaugh et al., 2003). First, we checked whether
NICD was upregulated in the ovary by Hes1 real-time PCR and
immunohistochemistry in ca-Notch1 ovaries. We found that Hes1
mRNA and protein levels were upregulated suggesting that NICD
is activated (supplementary Figs. S1C and S2E). Then we exam-
ined the ca-Notch1 ovaries. Histological analysis showed large
oocytes in the ca-Notch1 ovaries (Fig. 8A). In the ca-Notch1
ovaries, the average oocyte diameter showed a non-signiﬁcant
increase of around 20% (Fig. 8B). The number of oocytes show a
non-signiﬁcant decrease of about 20% in the ca-Notch1 ovaries
(Fig. 8C and D). Meiosis labeled by Sycp3 did not change (data not
shown). On the other hand, maturation of oocytes evaluated by
the Kit staining was enhanced in ca-Notch1 ovaries by about 40%
(Fig. 8E and G). Then we investigated different somatic markers.
The number of pregranulosa cells stained by Foxl2 decreased to
about 30% (Fig. 8F and H). The medula marker Ngfr increased inthe ca-Notch1 (Fig. 8I). By contrast, the endothelial cell marker
Pecam1 did not change compared to the control (data not shown).
These results suggest that overactivation of Notch induces some
opposite phenotypes to Hes1 KO, namely Hes1 expression,
maturation of oocytes and higher number of pregranulosa cells.
Reduced fertility in ovaries with somatic Notch pathway gene
alterations
Because of the defects in somatic Hes1 and Notch mutants, we
would also expect lower fertility. To test this hypothesis, we
generated adult mutant females and crossed them to WT male
mice. Fertility was evaluated by counting the number of pups. We
found that somatic Hes1 cKO showed a decrease of the pup
number at different ages (Fig. 9A). Somatic ca-Notch1 also
decreased the number of pups (Fig. 9B). The lower fertility in
these mutants can be explained by the lower number of oocytes
during fetal ovary development. It is possible that the quality
of oocytes is also decreased in these mutants. To examine
this possibility, we superovulated 11-months old control and
mutant female animals and counted the percentage of normal
oocytes with metaphase plate and polar body. In the Hes1 cKO
animals, there was a tendency to a lower number of oocytes, and
the number of normal oocytes also decreased (supplementary
Fig. 7. Fewer and smaller oocytes in the somatic cell-speciﬁc Hes1 cKO embryos. (A,B) Hematoxilin staining of parafﬁn sections and quantiﬁcation. The average diameter of
the cKO ovary is around 50% smaller than the control. (C,D) Immunoﬂuorescence of the oocyte marker Tra98 and quantiﬁcation. There is a 60% decrease of Tra98 positive
oocyte number in the Hes1 cKO. (E,G) Immunoﬂuorescence of the mature oocyte marker Kit and quantiﬁcation. The number of mature oocytes (Kit/Tra98 ratio) decreases
by about 20%. (F,H) Immunohistochemistry of the pregranulosa cell maker Foxl2 and quantiﬁcation. There is a non-signiﬁcant increase of Foxl2 positive cells in the cKO
ovaries. (I) Immunoﬂuorescence of the medulla marker Ngfr. Ngfr decreases in the Hes1 cKO (n¼2). Boxed regions are enlarged in the corners. Scale bars: 50 mm;
nnPo0.01, nnnPo0.001.
I. Manosalva et al. / Developmental Biology 375 (2013) 140–151148Fig. S14). In the ca-Notch1 animals, we did not get any oocyte, so
that it remains to be determined whether the total number or
quality is changed in this mutant. These results show that
appropriate expression levels of Notch pathway genes in ovarian
somatic cells are important for fertility.Discussion
There are currently few studies on the role of the Notch
pathway for the mammalian ovary development. The bHLH
transcription factor Hes1 is an important downstream component
of the Notch pathway, so that we examined ovaries deﬁcient for
the Hes1 gene. We found that deletion of the Hes1 gene in the
ovarian somatic cells decreases oocyte size and number. Hes1
deletion also decreased the number of oocytes with Kit protein, a
growth marker and antiapoptotic gene. Higher apoptosis might be
also explained by the upregulation of the proapoptotic gene
Inhbb. Ovary culture with a Notch inhibitor decreases Hes1
promoter activity and protein levels and induces similar pheno-
types as the Hes1 deletion mutants. Conversely, overactivation
of the Notch pathway in somatic cells upregulated Hes1 mRNA
and protein expression and induced some oposite phenotypes to
the Hes1 deletion mutant. Based on these results, we propose
that in the ovary, Hes1 expression is activated by the Notch
pathway (supplementary Fig. S15). Hes1 prevents apoptosis bya mechanism that might involve positive regulation of the Kit
pathway and negative regulation of Inhbb gene expression
(supplementary Fig. S15). Positive regulation of the Kit pathway
by Hes1 might be also necessary for oocyte growth and matura-
tion (supplementary Fig S15).
In invertebrates, it is well known that the Notch pathway is
required in the ovary (Klusza and Deng, 2011). Also in mammals,
chemical inhibition of Notch in neonatal ovaries affects the oocyte
follicle formation (Trombly et al., 2009). Hes1 is an important
downstream effector of the Notch pathway, and we and others
have found that Hes1 is mainly expressed in ovarian somatic cells
at fetal, neonatal and adult stages (Johnson et al., 2001; Trombly
et al., 2009). Our results show that the Notch pathway and Hes1
mainly act in somatic cells since somatic cell-speciﬁc Hes1 cKO
showed similar phenotypes to conventional Hes1 KO and DAPT
treatment.
Hes1 belongs to the family of Hes genes (Kageyama et al.,
2007). Genes of this family like Hes1, Hes3, Hes5 and Hey1 work
redundantly in different contexts like the inner ear and intestine
(Tateya et al., 2011; Ueo et al., 2012). In the mammalian ovary,
other Hes genes are expressed in addition to Hes1 (Trombly et al.,
2009) (data not shown). Therefore, Hes family genes might carry
out different functions redundantly in the ovary.
Meiosis is very important for oocyte development. It starts at
around E13.5, and by P0 almost all oocytes have reached the
dictyotene stage, which will be maintained until sexual maturity.
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Fig. 8. More mature oocytes and fewer pregranulosa cells in somatic cell-speciﬁc ca-Notch1 ovaries. (A,B) Hematoxilin staining of parafﬁn sections and quantiﬁcation.
The average diameter of the ca-Notch1 oocytes shows a non-signiﬁcant increase in the ca-Notch1 ovaries (B). (C,D) Immunoﬂuorescence of the oocyte marker Tra98 and
quantiﬁcation. There is a non-signiﬁcant 20% decrease of Tra98-positive oocyte number in the ca-Notch1 ovaries. (E,G) Immunoﬂuorescence of the mature oocyte marker
Kit and quantiﬁcation. The number of mature oocytes (Kit/Tra98 ratio) increases by about 40%. (F,H) Immunohistochemistry of the pregranulosa cell marker Foxl2 and
quantiﬁcation. The number of Foxl2 positive cells decreases in the ca-Notch1 ovaries. (I) Immunoﬂuorescence of the medulla marker Ngfr. Ngfr levels strongly increase.
Boxed regions are enlarged in the corners. Scale bars: 50 mm; nnPo0.01.
Fig. 9. Reduced fertility in ovaries with altered Notch pathway activity. The number
of pups for control, somatic Hes1 cKO (A) and somatic ca-Notch1 (B) female mice
were counted. We found a decrease of the average number of pups in the mutant
females.
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decreased fertility and abnormal meiotic maturation in adult
females (Hahn et al., 2005). In the Hes1 KO ovaries, we did not
ﬁnd meiotic defects after spreading and labeling the chromo-
somes with Sycp3, suggesting that Hes1 is not needed for meiotic
maturation.
Apoptosis is a normal physiological process in oocytes around
birth, when the oocyte number is reduced to about half (Ratts
et al., 1995). We have found that Hes1 is required for oocyte
survival, since we observe a decrease of oocytes in the Hes1 KO.Furthermore, this requirement is non-cell autonomous since
oocyte survival decreases in the somatic Hes1 cKO mice.
The increase of apoptosis correlated with higher expression of
the proapoptotic gene Inhbb, a member of the Tgfb family
(supplementary Fig. S15). Wnt4 mutation in the ovary increases
Inhbb expression and apoptosis, but the apoptosis is reverted by
simultaneous deletion of Inhbb and Wnt4 alleles (Liu et al., 2010).
One possibility is that higher Inhbb expression increases apoptosis
in the Hes1 KO ovaries. However, Inhbb is post-transcriptionally
inhibited by Fst, whose expression is also increased in Hes1 KO
ovaries (Fig. 3C) (Phillips and de Kretser 1998). We do not know
how Fst or Inhbb protein levels change in the Hes1 KO ovaries, so
that we cannot conclude that Inhbb is responsible for the
apoptosis phenotype. An experiment to prove the role of Inhbb
in the apoptosis phenotype of the Hes1 KO ovaries would be to
delete the Hes1 and Inhbb alleles simultaneously and check
whether the apoptosis of germ cells is reverted.
The higher expression of Inhbb in the Hes1 KO ovaries can be
explained in two ways (supplementary Fig. S15). One explanation
would be that the expression of Wnt4 is decreased, which then
results in higher expression of Inhbb (Liu et al., 2010). Another
explanation would be that Hes1 represses the Inhbb promoter
directly as shown in cultured cells here.
In the Hes1 KO ovaries, Fst mRNA expression is upregulated,
while Wnt4 mRNA expression is decreased (supplementary
Fig. S15). Fst expression was shown to be positively regulated
by Wnt4 raising the question of how Fst expression is increased
I. Manosalva et al. / Developmental Biology 375 (2013) 140–151150(Yao et al., 2004; Ottolenghi et al., 2007). Fst mRNA expression is
also positively regulated by Foxl2 overexpression in granulosa-
like cells (Kashimada et al., 2011). Moreover, most authors place
Foxl2 and Wnt4 in independent pathways (Liu et al., 2010; Veitia,
2010). Therefore, higher Foxl2 levels could explain higher Fst
mRNA expression in the Hes1 KO ovary (supplementary Fig. S15).
Another pathway linked to ovarian apoptosis is the Kitl/Kit
pathway, where the ligand Kitl in somatic cells activates the tyrosine
kinase receptor Kit in the oocytes (Driancourt et al., 2000). During
fetal development, a Kit antibody blocks the Kitl/Kit pathway and
increases apoptosis (Reynaud et al., 2000; Doneda et al., 2002). This
antiapoptotic effect of Kitl might be mediated by positive regulation
of the antiapoptotic factor Bcl2 via the Phosphoinositide 3-kinase
(PI3K) pathway (Jin et al., 2005). In the Hes1 KO ovaries, there is
lower Kitl and Kit expression, which might contribute to the
apoptosis phenotype (supplementary Fig. S15).
The Kitl/Kit pathway also promotes follicle maturation and
oocyte growth (Packer et al., 1994; Parrott and Skinner, 1999;
Driancourt et al., 2000). Kit mutant mice show abnormal follicle
maturation (John et al., 2009). For these reasons, lower Kitl and Kit
expression might explain the smaller and more immature oocytes
of Hes1 KO ovaries. Ngf is also important for the follicle number,
because Ngf KO ovaries show less primary and secondary follicles
(Dissen et al., 2001). Therefore, lower Kit and Ngf levels in the
Hes1 KO ovaries might contribute to the smaller oocytes (Parrott
and Skinner, 1999; Doneda et al., 2002; Dissen et al., 2001).
We have found that the number of pregranulosa cells and the
area of endothelial cells increase at E15.5. Furthermore, prolifera-
tion is also increased at E15.5, and this correlates with a decrease
of the expression of the cell cycle inhibitor Cdkn1c. These
observations suggest that proliferation and differentiation are
accelerated in the absence of Hes1, which could be explained if
Hes1 slows down differentiation of somatic cells to prevent
depletion of precursor cells at E15.5. In the nervous system,
Hes1 is expressed in neural stem cells (Kageyama et al., 2008).
In the absence of Notch signaling, neuronal differentiation is
accelerated and as a consequence, neuronal stem cells become
depleted (Imayoshi et al., 2010). In agreement with this explana-
tion, we ﬁnd that the marker of the precursors of pregranulosa
cells Lhx9 is decreased at E18.5 (Mazaud et al., 2002).
The decrease of precursors of pregranulosa cells could explain
why proliferation is decreased at E18.5. Another explanation
would be the expression increase of the cell cycle inhibitors
Cdkn1b and Gadd45g. Cdkn1b in the ovary is known to regulate
cell proliferation, because ovaries without Cdkn1b produce more
primary follicles (Rajareddy et al., 2007).
Previous reports have found that the female pregranulosa cell
factor Foxl2 represses the male Sertoli cell marker Sox9 (Yao et al.,
2006). However, we have found that in the Hes1 KO both genes
are activated raising the question of why Sox9 is upregulated. One
explanation would be that Sox9 is upregulated because Wnt4,
another repressor of Sox9, is downregulated (Yao et al., 2006).
Another explanation would be that Lhx9, a precursor of both
Foxl2 and Sox9, is downregulated (Mazaud et al., 2002).
The Notch pathway is very important for fetal development of
many organs, including invertebrate ovaries, but its role in
murine ovarian development is not well understood. Therefore,
our ﬁndings provide new insights into the mammalian ovary
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